Patient-Reported Outcomes studies
A Registry to Improve Care and Research in Lung Cancer Screening
This is an award to demonstrate the feasibility of developing a registry of individuals who undergo lung cancer screening with low-dose CT.
Developing a Risk Prediction Model and Evaluating the Economic Burden of Ankylosing Spondylitis in an Integrated Healthcare System
The primary aim is to develop an ankylosing spondylitis risk prediction model using data from Kaiser’s electronic medical records (EMR). We will also evaluate medical expenditure, health related quality of life and work productivity losses associated with ankylosing spondylitis.
Real World Effectiveness and Economic Impact of Subcutaneous Methotrexate compared to Oral Methotrexate Treatment for Rheumatoid Arthritis
This prospective study will evaluate the real-world effectiveness of subcutaneous vs. oral methotrexate treatment on disease activity and functional status of rheumatoid arthritis patients. We will also evaluate effectiveness on patient centered outcomes, treatment adherence, cost, and work productivity. Lastly, using a discrete choice experiment, we will estimate patient’s valuation of these outcomes and their willingness to pay.
Sleep Disturbance, Inflammation & Cellular Aging in Breast Cancer Survivors (STRIVE 2)
The goal of this prospective recruitment study is to evaluate longitudinal differences in the rates of change in inflammation and telomere erosion in breast cancer survivors vs. non-cancer comparison women to determine if such molecular changes are due to cancer biology, or its treatment, or consequences of aging.
Sleep Inflammation and Depression Occurrence in Breast Cancer Survivors (STRIVE1)
The aim of this prospective study is to examine the association between sleep disturbance, cellular and genomic markers of inflammation, and depression occurrence in breast cancer survivors.